Health News

Stay informed with the latest health industry news from around the globe. Read about advancements in health technology, updates in health insurance, innovations in medical devices, and more. Keep up with important health trends and industry developments.

Oct 17, 2026 at 8:30 AM

Prostate Cancer Foundation Expands Radiopharmaceutical Think Tank as Field Enters Pivotal Growth Phase

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) today announced the expansion of its Radiopharmaceutical Think Tank, adding new members and establishing its 2026-2027 agenda, which is focused on accelerating development and patient access of novel radiopharmaceutical drugs for cancer treatment. PCF is announcing the second year Think Tank program in conjunction with the European Association of Nuclear Medicine (EANM) Annual Congress, taking place October 17-21 in Vienna, Aust...
Oct 16, 2026 at 9:11 PM

Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court

SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, welcomes the decision of the Unified Patent Court (“UPC”) finding that aligner systems incorporating Angelalign’s Torque Ridges feature infringe Align’s European Patent EP 2 237 738 B1, which relates to Align’s Power Ridge® technology.In August 2025, Align initiated patent infring...
Oct 16, 2026 at 8:53 PM

Syncra and Neumetry Partner to Build AI-Powered Readiness Platform for Teenage Athletes and Their Coaches

LAS VEGAS & SAN JOSE, Calif.--(BUSINESS WIRE)--Syncra Labs Inc., maker of the Syncra smart ring, and Neumetry Medical, Inc., developer of an FDA-cleared predictive health platform, today announced a partnership to co-develop a readiness and recovery product for teenage athletes and the coaches who guide them. The product will combine continuous data from the Syncra ring with Neumetry's physiological waveform AI to give coaches a daily, evidence-based view of each athlete's readiness to train an...
Oct 16, 2026 at 7:38 PM

AHF Commemorates 40 Years of Global Impact During Annual World AIDS Day Concert Celebration Featuring Ricky Martin

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest, non-profit public health organization providing direct HIV/ADS services to over 3.3 million clients across the globe, will celebrate 40 years of impact during its annual World AIDS Day concert commemoration. Continuing his partnership with AHF, Ricky Martin will headline the free event scheduled for the evening of Monday, November 30, 2026, at the Kia Forum in Inglewood, California.Martin – a multi-award-winning...
Oct 16, 2026 at 4:45 PM

Quantum Foot and Ankle Group Welcomes Dr. Erick Benavides as Practice Expands Following New York Cosmos Partnership

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Quantum Foot and Ankle Group, PC, a foot and ankle surgery and sports medicine practice in Bergen County, today announced that Dr. Erick Benavides has joined the practice. The addition follows Dr. J. Adrian Wright’s appointment earlier this year as the official foot and ankle physician for the New York Cosmos. Dr. Benavides joins Dr. J. Adrian Wright and Dr. Alicia Kim in caring for patients at the Woodcliff Lake office and supporting Cosmos players. “Once...
Oct 16, 2026 at 4:38 PM

FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes

GENEVA--(BUSINESS WIRE)--FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes...
Oct 16, 2026 at 4:20 PM

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on October 15, 2026, it granted stock options to purchase shares of common stock to Stephen Aschettino, the Com...
Oct 16, 2026 at 4:15 PM

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the Company granted inducement equity awards covering an aggregate of 61,020 shares of its common stock to seven newly hired employees, consisting of inducement stock options to purchase an aggregate of 17,461 shares of common stock and inducement restricted stock units, covering an aggregate of 43,559 shares of its common stock. The awards are subject to all terms and conditions and other provisi...
Oct 16, 2026 at 3:57 PM

FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes

GENEVA--(BUSINESS WIRE)--FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes...
Oct 16, 2026 at 3:30 PM

Nephron Pharmaceuticals Announces Leadership Transition

WEST COLUMBIA, S.C.--(BUSINESS WIRE)--Nephron LLC and its subsidiaries (“Nephron” or the “Company”) today announced the departure of Lou Kennedy from her role as Chief Executive Officer. Haywood Miller has been appointed Interim Chief Executive Officer, effective immediately. Nephron enters this next chapter with the strong support of its secured lenders, who share confidence in the Company’s transformation strategy, growth priorities, long-standing customer relationships, and resilient manufac...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up